(Q45889179)

17 December 2017

title

Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model (English)

1 reference

17 December 2017

1 reference

1 reference

Nakamura H

1

1 reference

17 December 2017

Aoki M

2

1 reference

17 December 2017

Tamai K

3

1 reference

17 December 2017

Oishi M

4

1 reference

17 December 2017

Ogihara T

5

1 reference

17 December 2017

Kaneda Y

6

1 reference

17 December 2017

Morishita R

7

1 reference

17 December 2017

publication date

1 September 2002

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

18

1 reference

17 December 2017

page(s)

1221-1229

1 reference

17 December 2017

Atopic dermatitis: new insights and opportunities for therapeutic intervention

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

The role of lymphocytes in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Immune regulation in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Atopic dermatitis: from the genes to skin lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

NF-kappaB as a therapeutic target in chronic inflammation: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Role of dysregulated apoptosis in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Functional analysis of the human vascular cell adhesion molecule 1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

7 January 2021

NC/Nga mice: a mouse model for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

7 January 2021

Tacrolimus ointment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

7 January 2021

Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

7 January 2021

Safety of intracoronary administration of c-myc antisense oligomers after percutaneous transluminal coronary angioplasty (PTCA)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

7 January 2021

An improved immunofluorescence technique for the histological examination of blood vessel tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

7 January 2021

Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301724

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301724

1 reference

17 December 2017

Dimensions Publication ID

1048680111

0 references

1 reference

17 December 2017